Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
Open Access
- 10 April 2023
- journal article
- Published by The Journal of Health Economics and Outcomes Research in Journal of Health Economics and Outcomes Research
- Vol. 10 (1)
Abstract
Background: Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients’ health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we used vignette (scenario) construction and valuation to develop health state utilities. Objectives: The aim of this study was to use vignette construction and valuation to estimate health state utility values suitable for inclusion in economic models of FD treatments. Methods: Health state vignettes were developed from semistructured qualitative telephone interviews with patients with FD and informed by published literature and input from an expert. Each vignette was valued in an online survey by members of the United Kingdom (UK) general population using the composite time trade-off (TTO) method, which aims to determine the time the respondent would trade to live in full health compared with each impaired health state. Results: Eight adults (50% women) with FD from the UK were interviewed. They were recruited via various approaches, including patient organizations and social media. The interviewees’ responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD [CEFD], severe CEFD, end-stage renal disease [ESRD], stroke, and cardiovascular disease [CVD]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). A vignette valuation survey was administered to 1222 participants from the UK general population who were members of an external surveying organization and agreed to participate in this study; 1175 surveys were successfully completed and included in the analysis. Responses to TTO questions were converted into utility values for each health state. Pain was the highest valued health state (0.465), and severe CEFD + ESRD was the lowest (0.033). Discussion: Overall, mean utility values declined as the severity of the vignettes increased, indicating that respondents were more willing to trade life-years to avoid a severe health state. Conclusions: Health state vignettes reflect the effects of FD on all major health-related quality-of-life domains and may help to support economic modeling for treatment of FD.Keywords
This publication has 32 references indexed in Scilit:
- Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey StudyClinical Therapeutics, 2020
- Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort studyJournal of Inherited Metabolic Disease, 2017
- Experience-based utility and own health state valuation for a health state classification system: why and how to do itThe European Journal of Health Economics, 2017
- Valuing health-related quality of life: An EQ-5D-5L value set for EnglandHealth Economics, 2017
- EuroQol Protocols for Time Trade-Off Valuation of Health OutcomesPharmacoEconomics, 2016
- Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UKValue in Health, 2013
- Introducing the composite time trade-off: a test of feasibility and face validityThe European Journal of Health Economics, 2013
- Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health TechnologiesValue in Health, 2012
- Fabry disease in children and the effects of enzyme replacement treatmentEuropean Journal of Pediatrics, 2009
- Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaintsQuality of Life Research, 2007